Discover how the 340B drug pricing program, intended to help low-income patients, has become a system of abuse and misuse ...

Users report positive results, experiencing increased energy levels, improved mental clarity, and better health. The competitive pricing and the risk-free 180-day money-back guarantee add further ...

Numerous brands are skimping on the number of sheets, according to the number crunchers. The analytics cited one culprit, ...

In March 2024, Rezdiffra™ (resmetirom) was the first drug approved in MASH in the United States ... and Exchange Commission ("SEC"), including the Company’s 2023 Annual Report on Form 20-F filed with ...

KB Brown’s phone hasn’t stopped ringing since Walgreens shut its W. Broadway store last year, leaving one pharmacy to serve 67,000 residents in the north Minneapolis area where he lives and runs his ...

Thus, I am upgrading ALT stock to a “Strong Buy” due to the promising progress of its lead drug candidate, sufficient runway ...

Hims & Hers Health on Wednesday launched a tracker for popular weight-loss and diabetes drugs that allows patients to share details about their challenges finding treatments such as Novo Nordisk's ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion sales in 2023, it shows no signs ...

Last patient completed pivotal Phase 3 trial in CHB-associated liver fibrosis in the PRC with data expected in Q1 2025 On track to initiate U.S. Phase 2 trial of F351 in MASH-associated liver fibrosis ...

Harding Loevner Global Small Companies Equity composite advanced 8%, gross, during Q3 2024, trailing the 8.9% gain in the ...

What Happened: The legal spat stems from the federal 340B Drug Pricing Program, which provides discounted medications to ...

Saudi Arabia Pharmaceutical Drugs Market Projected To Witness Substantial Growth, 2024-2031: Pfizer Inc., Sanofi S. A. Saudi Arabia Pharmaceutical Drugs Market is estimated to be valued at US$ 12.60 ...